In the News


Genomic Health and Cleveland Diagnostics Announce Strategic Collaboration to Develop and Commercialize New Prostate Cancer Tests

Genomic Health, Inc. (Nasdaq: GHDX), the world's leading provider of genomic-based diagnostic tests, and Cleveland Diagnostics, Inc., a biotechnology company focused on developing next-generation diagnostics technology for the detection of cancers, today announced an exclusive licensing agreement to develop and commercialize new prostate cancer tests based on Cleveland Diagnostics' IsoPSA™ reagents and technology.


Cleveland Clinic partners with Silicon Valley accelerator to pilot digital health startups

The Cleveland Clinic has launched a three-year partnership with two technology startups—including one with deep ties to Silicon Valley investors—with a focus on developing new innovative healthcare tools.


CLE Clinic to Lure Tech Startups to NEO

The city's largest health care employer is making moves to attract health tech startups to the city. 


Cleveland Clinic and JumpStart Partner to Bring Plug and Play Accelerator to the Global Center for Health Innovation

Cleveland Clinic and JumpStart Inc. have announced a three-year partnership with Silicon Valley's renowned Plug and Play to create an Accelerator focused on biotech and digital health innovation in downtown Cleveland's Global Center for Health Innovation.


Global innovation firm Plug and Play to partner with Cleveland Clinic, JumpStart on health innovation

Plug and Play, a global business that's nurtured companies like Google, Paypal and Dropbox, is coming to Cleveland.


Silicon Valley company plugs into Cleveland

A renowned Silicon Valley innovation company is coming to Cleveland to help create an accelerator focused on biotech and digital health innovation and attract companies and startups from around the world.


Quest Diagnostics to acquire Cleveland Clinic spinoff Cleveland HeartLab

Quest Diagnostics signed a deal with Cleveland Clinic spinoff Cleveland HeartLab to acquire the company before the end of the year.


3rd Annual Cleveland Medical Hackathon to Take on Population Health, Precision Medicine, Public Health, and the Opioid Crisis

This fall, the 3rd Annual Cleveland Medical Hackathon will once again deliver an innovative jolt to the healthcare industry. Students, doctors, nurses, public health officials, developers, designers, engineers, researchers, and community members will gather at the Global Center for Health Innovation October 21 - 22 for a high-energy, all-night, problem-solving session.


ClearFlow, Inc. Announces Positive US Clinical Trial Results

ClearFlow, Inc., a medical device company based in Anaheim, California, announced today that positive clinical trial results were presented at the International Coronary Congress (ICC) 2017 annual meeting on August 18th, 2017 in New York City, NY. The findings were presented by the study principal investigator, Dr. Yvon Baribeau, of Catholic Medical Center in Manchester, New Hampshire, in a presentation titled “Active Clearance of Chest Drains Reduces Retained Blood and ICU Resources after Off-Pump Coronary Artery Bypass Surgery.”


Pathway to obesity: Study links TMAO-producing gut bacteria to obesity risk

The way bacteria in our gut metabolise the foods we eat could have a strong impact on obesity risk, while blocking certain pathways could lead to prevention, say researchers.

   <  1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >   

Get In Touch With Us